Amylin signs weight-loss drug deal with Takeda
The Associated Press
The deal includes two potential weight-loss treatments, a pramlintide-metreleptin combination and davalintide. Both potential drugs are in midstage,
Amylin forges $1B weight-loss pact with TakedaFierceBiotech
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss DrugsXconomy
Takeda Agrees to Buy Rights to Amylin's Obesity DrugsBloomberg

all 143 news articles »